Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 331-338

  Tell, Robert ^a,b   Wang, Q Tian ^a,b   Blunier, Adam ^a,b   Benya, Richard V ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Bombesin; Metastasis

Indexed keywords

BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; GENOMIC DNA; HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1 ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FAM13A GENE; GBE1 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MAPPING; GENOME ANALYSIS; IL1RAPL2 GENE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; PLK3 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SLCO1B3 GENE; UPREGULATION;

EID: 84863067927     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-011-0027-5     Document Type: Article

References (33)

1. Birch AH, Quinn MC et al (2008) Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes. Mol Carcinog 47:56-65
2. Carroll RE, Matkowskyj KA et al (1999) Aberrant expression of gastrin-releasing peptide and its receptor by well differentiated colon cancers in humans. Am J Physiol 276:G655-G665 (Pubitemid 29157431)
3. Carroll RE, Matkowskyj KA et al (2002) Contribution of gastrinreleasing peptide and its receptor to villus development in the murine and human gastrointestinal tract. Mech Dev 113:121-130 (Pubitemid 34311738)
4. Cohen M, Reichenstein M et al (2004) Cloning and characterization of FAM13A1-a gene near a milk protein QTL on BTA6: evidence for population-wide linkage disequilibrium in Israeli Holsteins. Genomics 84:374-383 (Pubitemid 38834174)
5. Dai W, Liu T et al (2002) Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 20:121-126
6. Dialynas GK, Vitalini MWet al (2008) Linking heterochromatin protein 1 (HP1) to cancer progression. Mutat Res 647(1-2):13-20
7. Grewal SI, Jia S (2007) Heterochromatin revisited. Nat Rev Genet 8 (1):35-46 (Pubitemid 46006048)
8. Hamada A, Sissung T et al (2008) Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 14:3312-3318
9. Jensen JG, Carroll RE et al (2001) The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer. Peptides 22:689-699 (Pubitemid 32322728)
10. Jensen RT, Battey JF et al (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60(1):1-42 (Pubitemid 351439216)
11. Johnson EF, Stewart KD et al (2007) Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry 46:9551-9563 (Pubitemid 47291962)
12. Kalliokoski A, Niemi M (2009) Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693-705
13. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410:120-124 (Pubitemid 32225848)
14. Kirschmann DA, Lininger RA et al (2000) Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res 60(13):3359-3363 (Pubitemid 30482146)
15. Lando M, HoldenM et al (2009) Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLos Genet 5(11):e1000719
16. Langmead B, Trapnell C et al (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25
17. Lee YC, Chang CJ et al (2010) Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insights into glycogen storage disease IV. Hum Mol Genet 20(3):455-465
18. Maloney A, Clarke PA et al (2007) Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res 67(7):3239-3253 (Pubitemid 46724862)
19. Muto M, Onogawa T et al (2007) Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci 98:1570-1576 (Pubitemid 47308452)
20. Nishimura K, Hirokawa YS et al (2006) Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells. Anticancer Res 26 (6B):4349-4356 (Pubitemid 46031508)
21. Norwood LE, Grade SK et al (2004) Conserved properties of HP1 (Hsalpha). Gene 336(1):37-46
22. Norwood LE, Moss TJ et al (2006) A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion. J Biol Chem 281(27):18668-18676 (Pubitemid 44035527)
23. Oshio H, Abe T et al (2008) Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines. J Gastroenterol 43:538-549
24. Pellegrino R, Calvisi DF et al (2010) Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51:857-868
25. Piton A, Michaud JL et al (2008) Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 17:3965-3974 (Pubitemid 352762857)
26. Pomeroy SL, Tamayo P et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415(6870):436-442 (Pubitemid 34100955)
27. Ruginis TA, Taglia L et al (2006) Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach. J Proteome Res 5:1460-1468 (Pubitemid 43865814)
28. Smith NF, Acharya MR et al (2005) Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol Ther 4:815-818
29. Takanashi M, Oikawa K et al (2009) Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol 174(1):309-316
30. Tell R, Rivera CA et al (2011) Gastrin-releasing peptide signaling alters colon cancer invasiveness via heterochromatin protein 1Hsβ. Am J Pathol 178(2):672-678
31. WaseniusVM, Hemmer S et al (2003) Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 9(1):68-75
32. Yang Y, Bai J et al (2008) Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions. Cancer Res 68:4077-4085
33. Zhang Y, Liu T et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137